Premium
Utilization of health care services in cancer patients with elevated fear of cancer recurrence
Author(s) -
Champagne Alexandra,
Ivers Hans,
Savard Josée
Publication year - 2018
Publication title -
psycho‐oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.41
H-Index - 137
eISSN - 1099-1611
pISSN - 1057-9249
DOI - 10.1002/pon.4748
Subject(s) - psychosocial , medicine , insomnia , cancer , psychiatry , cancer recurrence , depression (economics) , health care , health professionals , family medicine , economics , macroeconomics , economic growth
Background Cancer patients commonly report experiencing fear of cancer recurrence (FCR), which may lead to several negative consequences. This study aimed at examining whether clinical levels of FCR are linked to a greater use of health care services. Method This is a secondary analysis of a longitudinal study of 962 cancer patients on the epidemiology of cancer‐related insomnia. They completed the Fear of Cancer Recurrence Inventory—Short form (FCRI‐SF) and reported information on their consultations (medical, psychosocial, and complementary and alternative medicine [CAM]) and medication usage (anxiolytics/hypnotics and antidepressants) at 6 time points over an 18‐month period. Results Results indicated that clinical FCR at baseline was associated with greater consultation rates of medical and psychosocial professionals and a greater usage of anxiolytics/hypnotics and antidepressants. No significant association was found between the FCR level and use of CAM services. While consultation rates of medical and CAM professionals and usage of antidepressants generally increased over time, consultation rates of psychosocial professionals and usage of anxiolytics/hypnotics tended to decrease. Conclusions Cancer patients with clinical levels of FCR are more likely to consult health care providers and to use psychotropic medications, which may translate into significant costs for society and the patients themselves.